Professor Häring heads the Institute for Diabetes Research and Metabolic Diseases, a research cooperation of Helmholtz Zentrum München and the University hospital Tübingen. In Tübingen, Häring is also the director of the Medizinische Universitätsklinik, Internal Medicine IV for endocrinology, diabetology, angiology, nephrology and clinical chemistry.
Häring’s research work focuses on the genetic and environmental foundations of type 2 diabetes, with the objective of characterizing biochemical, genetic and epigenetic mechanisms leading from pre-diabetes to manifest diabetes. The recognized diabetes expert pursues the goal to improve early diagnosis of diabetes and detection of diabetic risk, in order to develop novel prevention strategies and approaches to personalised therapy for this widespread disease.
Within the DZD, too Häring has essentially contributed to establish clinical studies for diabetes such as the German pre-diabetes intervention study (PLIS).

About the Institute for Diabetes Research and Metabolic Diseases

About the Leopoldina: The Leopoldina was founded in 1652 as a society for the natural sciences and medicine and currently has more than 1,400 members from Germany and other countries. It is Germany's oldest academy and was named the National Academy of Sciences in 2008 by Germany's federal and Land governments. The Leopoldina represents the German scientific community in international committees and carries out a science-based consultation function for the political sector and society.